OSR Health, Inc. (OSRH)
OTCMKTS · Delayed Price · Currency is USD
0.1700
+0.0025 (1.49%)
At close: Aug 27, 2026
OSR Health Revenue
OSR Health had revenue of $315.67K in the quarter ending June 30, 2026, a decrease of -72.20%. This brings the company's revenue in the last twelve months to $1.81M, down -50.24% year-over-year. In the year 2025, OSR Health had annual revenue of $2.91M, down -17.69%.
Revenue (ttm)
1.81M
Revenue Growth
-50.24%
P/S Ratio
3.30
Revenue / Employee
n/a
Employees
22
Market Cap
5.97M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.91M | -624.50K | -17.69% |
| Dec 31, 2024 | 3.53M | - | - |
| Dec 31, 2023 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
OSR Health News
- 18 hours ago - Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc. - Accesswire
- 6 days ago - OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission - Accesswire
- 8 days ago - OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal - Accesswire
- 9 days ago - OSR Health Sees Global Shareholder Momentum at Critical Inflection Point - Accesswire
- 17 days ago - OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development - Accesswire
- 20 days ago - OSR Health Issues Clarification Regarding Prior Nasdaq Communication and Shareholder Loyalty CVR Program - Accesswire
- 25 days ago - Vaximm AG, an OSR Company, Announces Forthcoming Publication of Cross-Indication Clinical Data for VXM01, Its VEGFR-2-Targeted Cancer Vaccine Platform - Accesswire
- 27 days ago - OSR Health Secures Nasdaq Communication: Loyalty CVR Program Will Not Trigger a Price Adjustment - Accesswire